Clinical Trial Update: Expanded Access for the Treatment of Advanced Cholangiocarcinoma With ABC294640 (Yeliva ®)

View source ↗

Summary

Expanded Access for ABC294640 (Yeliva) in advanced cholangiocarcinoma has been closed and is no longer available.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholangiocarcinoma
• Extrahepatic Cholangiocarcinoma
• Intrahepatic Cholangiocarcinoma
• Perihilar Cholangiocarcinoma

Drugs mentioned

• Yeliva (ABC294640)

Snippet

Sponsor: RedHill Biopharma Limited | Conditions: Cholangiocarcinoma, Cholangiocarcinoma Non-resectable | Status: NO_LONGER_AVAILABLE